Attachment B - Vendor Feedback Form 75F40125Q00090 NCB.docx
DOCX document 20 KB Posted
- Attached to
- Research and Development of the FDA ARGOS System
- Solicitation number
- 75F40125Q00090
About this file
This is a Vendor Feedback Form (Attachment B) designed to gather information from potential vendors for a Sources Sought Notice related to the FDA ARGOS System research and development opportunity (75F40125Q00090). The form requires vendors to indicate their capability to provide services outlined in the Draft Statement of Objectives, including experience across eight specific task areas. Vendors must provide detailed past performance information including contract numbers, periods of performance, values, and customer names for similar work.
The form includes questions about vendors' existing contract vehicles that FDA could potentially utilize, GSA Schedule contract information, and recommended NAICS codes (FDA is considering 541714 - Research and Development in Biotechnology). Vendors must submit their responses by February 5, 2025 at 2:00 PM EST to the specified Contracting Officer and Contract Specialist. The form serves as a market research tool to help FDA determine qualified vendors' capabilities and potential acquisition strategies for developing bioinformatics tools, AI tools, and NGS-based genetic analysis methodologies for the FDA ARGOS database system.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Sources Sought Notice 75F40125Q00090 NCB.docx | DOCX document | |
| STATEMENT OF OBJECTIVES for IDIQ_V6_1.16.25 kdp12225 clean version.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Attachment B - Vendor Feedback Form
Vendor/Company Name:
1. Is your company capable of providing all the requested services found within the Draft STATEMENT OF OBJECTIVES (SOO)? If NO is selected, which service(s) is/are your company not able to provide?
☐ YES ☐ NO
2. Does your company provide the services under an existing contract vehicle, that the FDA may utilize the existing contract for the requested services found within the Draft STATEMENT OF OBJECTIVES (SOO)?
☐ YES ☐ NO ☐ N/A
If yes is selected, please list contract number(s) and provide ordering instructions.
For questions 3 through 11, interested offerors must provide a description of their experience in providing the requested services, to include: contract numbers, performance period, contract value, customer name, and indication whether interested offeror acted as the prime or a sub under the contract.
3. Provide your company’s specific and relevant experience in providing the same or similar services as outlined in (Objectives) of the DRAFT SOO.
4. Provide your company’s specific and relevant experience in providing the same or similar services as outlined in Task 1 in the DRAFT SOO.
5. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 2 in the DRAFT SOO.
6. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 3 in the DRAFT SOO.
7. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 4 in the DRAFT SOO.
8. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 5 in the DRAFT SOO
9. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 6 in the DRAFT SOO.
10. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 7 in the DRAFT SOO.
11 Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 8 in the DRAFT SOO.
12. Did you provide comments/feedback on the DRAFT SOO? Interested offerors are highly encouraged to provide comments/feedback on the DRAFT documents.
☐ YES ☐ NO
13. What NAICS code would your company recommend for this requirement? The FDA is considering 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
14. Can your company provide a list of all of tasks under your existing GSA Schedule contract, if applicable?
15. Does your company’s existing GSA schedule contract(s) cover the anticipated period of performance, if applicable.
16. List GSA schedule contract number(s) that would be applicable to this requirement.
File details come from the government source that posted it. Updated .